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Abstract
Endometriosis is tightly linked to infertility which is manifested at very early or more advanced stages of the gestational cycle.
Alteration on the production of a great number of cytokines/growth factors can be accused for problems on ovum maturation,
fertilization or implantation. Yet, macroscopically these stages are characterized by the inability of conception. A closer look of
the cytokinic proﬁle during the conceptional and early gestational cycle could, however, localize the problem and allow a
therapeutic approach. In this commentary, going through the cytokine requirement during ovulation, fertilization and the
early stages of pregnancy, it became possible to speciﬁcally deﬁne the harmful endometriosis-induced cytokines for each of the
conceptional and early gestational stages. Thus, regulating the levels of interferon-g and tumor necrosis-a will facilitate
ovulation and fertilization, whereas adjusting the levels of interleukin-1b and colony stimulating gactor-1 will facilitate
implantation.
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Endometriosis by deﬁnition concerns the migration,
implantation, growth and function of endometrial
tissue mainly to the peritoneum, on or next to the
ovaries and less frequently to the cul-de-sac, utero-
sacral ligaments, fallopian tubes, vagina, urinary track
(20% of cases) or even to the gastrointestinal tract
(12–37% of patients) and rarely to the lungs, arms
or thighs. The endometrioma once successfully
implanted mimics the functions of the physiologic
endometrium and follows menstruation. Thus, every
month endometriomas ﬁll with blood, thicken, break
down and bleed. Yet, in the absence of a natural root
for the blood to exit, the implants develop into
endometriotic cysts, spots or patches, which may grow
and reseed as the menstrual cycle continues. Although
endometriomas are not cancerous they can develop
and attach to nearby organs. Symptoms of
endometriosis, depending on the localization of the
implants,includegraduallyincreasingpaintothelower
abdomen during or before menstruation, dysparenia,
disuria, hypo- or hyper-blood release during men-
struation and infertility, which accompanies 75% of
the patients. Assuming that the fallopian tubes are
permissive and ovulation occurs normally, an import-
ant mechanical cause for infertility includes the
limited elasticity of organs, which diminishes the
possibility of ovum uptake by the fallopian tubes
(Lebovic et al. 2001). An additional and perhaps more
important parameter to infertility is the cytokine
imbalance induced by endometriomas.
Cytokines in endometriosis
Endometriomas, by mimicking the functions of the
physiologic endometrium, are subjected to a similar
hormonal regulation ensuring thus thickening and
development of blood vessels. Since, however, such
changes do not occur in the privileged site of
the uterus, they trigger systemic mechanisms
to the female organism leading to signiﬁcant
changes of the cytokinic proﬁle. Thus, interleukin-1b
(IL-1b) and the vascular endothelial growth
factor (VEGF) increase in the serum of endo-
metriotic women possibly to facilitate angiogenesis
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increases in case of endometriosis ensuring prolifer-
ation of endometrial cells, stimulates decidualization
but becomes toxic to the late embryo (Wu and Ho
2003). The increased levels of interleukin-8 (IL-8)
attract neutrophils to the endometriotic sites and
facilitate angiogenesis (Wu and Ho 2003). By the
same token, interleukin-10 (IL-10) and colony
stimulating factor-1 (CSF-1) increase in the serum
of endometriotic women probably due to high
numbers of activated macrophages in the endo-
metrium (Wu and Ho 2003, Fukaya et al. 1994).
Granulocyte-macrophage colony stimulating factor
(GM-CSF) is also found to increase in endo-
metriosis, especially during the secretory phase of
the menstrual cycle (Wu and Ho 2003). The
increased levels of tumor necrosis factor-a (TNF-
a) during endometriosis ensure agglutination of
endometrial cells to the epithelium (Wu and Ho
2003). Similarly, interferon-g (IFN-g) is also found
increased in the serum and peritoneal ﬂuid of
endometriotic women (Wu and Ho 2003). Inter-
leukin-15 (IL-15) is known to induce production of
IFN-g and increases in the peritoneal ﬂuid of
endometriotic women as well (Arici et al. 2003).
In addition to cytokines, another family of immune
molecules found to be disturbed during endometriosis
includes soluble HLA molecules. The levels of soluble
class-I and class-II HLA proteins are found to
signiﬁcantly decrease in the serum of women suffering
from endometriosis (Matalliotakis et al. 2001). Yet,
there is no information on whether and how these
molecules can affect the early gestational stages.
Cytokines in ovulation, fertilization and early
embryo development
Cytokines are still believed to be very important
regulatory molecules not only for the immune system,
but for many other signiﬁcant functions of the
organism. Yet, the complicated mechanisms of their
regulation, including regulation of their cellular
receptors, their synergistic and/or antagonistic inter-
active nature and their differential production upon
the various cellular stimuli, make these molecules very
difﬁcult to study and more importantly very compli-
cated to use in therapeutic treatments.
The reproductive process is now known to be
directlylinkedtothecytokinicregulation.Thus,during
ovulation, gonadotropins (follicular stimulating hor-
mone-FSH- and luteinizing hormone-LH-) simul-
taneously activate production of the plasminogen
activator with both TNF-a and IL-1b and lead to
follicular rupture (Figure 1). The plasminogen
activator pathway goes through activation of plasmin.
In turn, plasmin stimulates collagenases, which
actually induce rupture of the follicle and ovulation.
On the other hand, TNF-a and IL-1b are involved in
two different pathways leading to the follicular rupture
(Machelon and Emilie 1997, Adashi 1990, Adashi
1998). The ﬁrst is via prostaglandins which, by
increasingvascularpermeability,facilitatethefollicular
rupture and the second is via nitrogen oxide (NO)
leading directly to follicular rupture. By the same
token,TNF-aandIL-1bstimulateproductionofGM-
CSF and IL-8, cytokines that will further facilitate
ovulation and embryo implantation (Arici et al. 1996).
Atthatstage,IL-6andIFN-garealsobeingdetectedin
the endometrium possibly accounting for NO pro-
duction (Athanassakis et al. 1999).
Speciﬁcally for IFN-g,i ts e e m st h a tt h i sa g e n ta c t si n
very narrow timing windows, since itbecomesundetect-
able after the follicular rupture and if present, under not
physiological conditions, inhibits estrogen disallowing
thus ovulation. At the same time IFN-g inhibits sperm
mobility acting as a negative parameter to fertilization
(Machelon and Emilie 1997). Similar effects apply to
TNF-a, which although facilitating follicular rupture
itself through NO and prostaglandin synthesis, inhibits
the plasminogen activity (Karakji and Tsang 1995) and,
if present in a later stage of the reproductive cycle, will
inhibit steroid biosynthesis, sperm mobility and sperm/
mucus interaction (Machelon and Emilie 1997,
Sato et al. 1995).
Upon fertilization, although the early embryo
produces its own cytokines to support growth, it is
tightly dependent on maternal endometrium for
implantation (Table I). Thus, the two-cell stage
embryo produces small quantities of TNF-a and
IFN-g possibly to initiate an inﬂammatory reaction to
the endometrium preparing implantation. However,
high concentrations of IFN-g and TNF-a are toxic
to the two-cell stage embryos. At the stage of
blastocyst the trophectoderm produces IL-10, IL-3
and IL-6, the zona pellucida produces GM-CSF
Figure 1. Hormones and cytokines involved in the process of
ovulation.
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(Athanassakis et al. 1999). Among these cytokines,
IL-10, IL-3 and GM-CSF facilitate embryo growth
(Athanassakis et al. 1987) whereas IL-6 is involved in
the inﬂammatory reaction during implantation.
During the preparative stage of embryo implantation,
GM-CSF and IL-3 are present in the endometrium,
IL-10 in the endometrium/ myometrium, IL-1 and
CSF-1 are produced by the mesometrium, uterine
epithelium and endometrium, TNF-a and IFN-g are
present in the mesometrium and IL-6 is found to be
also produced by endometrium and is present in the
endometrium/myometrium during implantation
(Adashi 1998, Araki et al. 1996).
Once implantation is completed, TNF-aand IFN-g
will play an important role in trophoblast cell
differentiation/maturation (Athanassakis et al. 2000),
whereas IL-6 will induce decidualization in the uterus
(Machelon and Emilie 1997). All these cytokines are
harmful to the late embryo and at higher concen-
trations induce fetal abortion. On the other hand,
GM-CSF, CSF-1 and IL-3 improve trophoblast
proliferation and function (Athanassakis et al. 1987),
whereas IL-10 promotes late embryo development
(Wegmann et al. 1993).
Endometriosis and cytokine-induced infertility
Considering the cytokine pathology during endo-
metriosis and the cytokine requirement for ovulation,
fertilization and early embryo development, it is not
difﬁcult to foresee how endometriosis correlates to
infertility (Table II). However, if one screens all
cytokines induced in endometriosis one by one, it will
be realized that only four to up-to-now knowledge
cytokines are mainly responsible for disallowing
conception. Namely, the increased levels of IFN-g
and TNF-a in the serum of endometriotic women,
although facilitating follicular rupture, inhibit ovula-
tion by acting as negative regulators on steroid
biosynthesis [especially estrogen; Machelon and
Emilie 1997, Karakji and Tsang 1995, Terranova
and Rice 1997]. Although not fully explained, there
are reports in the literature showing that the ovarian
function is altered in signiﬁcant number of fertile
women with endometriosis (Winglﬁeld et al. 1994,
Bulletti et al. 2002). These two factors will also exert a
negative effect on fertilization since they will decrease
sperm mobility while TNF-a will also inhibit
sperm/mucus interaction. Even if the ovum succeeds
to get fertilized, the elevated concentrations of these
two cytokines will be toxic to the two-cell stage
embryo. IL-8 which, as previously described, exerts a
positive effect in ovulation, in most cases of women
can not apparentlyovercome the negativeeffects of the
elevated IFN-g and TNF-a concentration.
The next two cytokines, that negatively affect these
early stages of pregnancyestablishment, are IL-1b and
CSF-1 acting as embryo implantation inhibitors
(Araki et al. 1996, Terranova and Rice 1997).
As discussed earlier, IL-1b is inducing ovulation by
facilitating follicular rupture but, if its production in
the uterus persists, it inhibits embryo implantation.
Similarly, CSF-1 facilitates ovulation and promotes
trophoblast growth of the late embryo but, always
within the narrow timing of implantation, it exerts
Table I. Cytokine production at different stages of early embryo development.
Stage of embryo development Cytokines
Fertilisation
† TNF-a inhibits sperm mobility and sperm/mucus interaction
† IFN-g inhibits sperm mobility
Two-cell embryo
† Produces small quantities of TNF-a and IFN-g
† At higher concentrations TNF-a and IFN-g become toxic
Blastocyst
† Trophectoderm: IL-3, IL-6, IL-10
† Inner cell mass: IL-10
† Zona pellucida: GM-CSF
Embryo implantation
† Endometrium: GM-CSF, IL-3, IL-10, IL-6
† Mesometrium: IL-1, CSF-1, TNF-a, IFN-g
† Myometrium: IL-10, IL-6
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anchorage to the endometrium.
If, however, implantation occurs, all the other
cytokines known to be induced up-to-now in
endometriotic women have positive effects on embryo
development. Namely, GM-CSF, CSF-1 and IL-10
will stimulate trophoblast growth/ function and
embryo development (Athanassakis et al. 1987,
Athanassakis-Vassiliadis et al. 1993).
Indeed,thisinabilitytoconceptionandearlyembryo
loss in endometriotic women explains the lack of
correlation between endometriosis and recurrent
abortion.
Recurrent abortions have been correlated to cyto-
kineimbalanceaswellastodisturbanceofsolubleHLA
levels in the maternal serum (Athanassakis et al. 1999)
and are deﬁned as the occurrence of three or more
clinicallyrecognizedfetallossesbeforethe20thweekof
pregnancy when no gynecological, pathological or
genetic problems have been detected. Based on the
deﬁnitions given above, endometriosis and recurrent
abortions do not seem to have a direct correlation.
Various studies have tried to examine this issue, yet
because of the lack of valid controls, it has become
difﬁculttoevaluatethedescribedresults.Incontrastto
onlyonestudy,mostreportsfailgenerallytoestablisha
correlation between endometriosis and recurrent
abortion (Vercammen and D’Hooghe 2000). Thus,
Vercammen andD’Hooghe2000,Marcouxet al.1997
have shown that fetal losses occur with the same
frequency in endometriotic women with or without
surgical treatment of endometriosis. Similarly,
Matorras and Rodriguez 1998 showed that 7% of
their patients with endometriosis underwent recurrent
abortion as compared to 6% of recurrent abortions in
patients without endometriosis. In other groups of
patients, 45% of women with endometriosis were also
suffering from recurrent abortions, whereas 34% of
their recurrent aborters did not have any signs
of endometriosis (Vercammen and D’Hooghe, 2000).
In general, many reports claim that the occurrence of
recurrent abortions does not show to increase in
women suffering from endometriosis, probably due to
the fact that infertility in endometriotic women occurs
during the early conceptional and gestational stages
(FitzSimmons et al. 1987, Pittaway et al. 1988).
However, if an endometriotic woman successfully
overcomes the early gestational stages she could
develop symptoms of recurrent abortion because of
the imbalance of cytokines and soluble HLA antigens
already established to her organism.
Conclusion
As it can be realized, the cytokine induced infertility in
endometriotic women is a multi-parameter event.
Not all women develop the same levels of cytokines at
the same time. Ovulation, fertilization and embryo
Table II. Comparative effect of cytokines in endometriosis and pregnancy.
Endometriosis Pregnancy
IL-1b † Increases † Necessary to ovulation
† Promotes angiogenesis † Implantation inhibitor
IL-2 † Increases † Stable levels
IL-3 Information not available † Promotes implantation
† Promotes growth/function of mature trophoblasts
IL-6 † Increases † Activates decidualization
† Promotes growth of endometrial cells † Harmful to late embryo
IL-8 † Increases † Necessary to ovulation
† Attracts neutrophils
† Promotes angiogenesis
IL-10 † Increases † Promotes fetal development
CSF-1 † Increases † Necessary to ovulation
† Implantation inhibitor
† Promotes growth/ function of mature trophoblasts
GM-CSF † Increases in endometrial cells especially
during the secretory phase
† Necessary to ovulation
† Promotes implantation
† Promotes growth/function of mature trophoblasts
TNF-a † Increases † Inhibits steroid biosynthesis
† Facilitates adherence of endometriotic
cells to peritoneal mesothelium
† Inhibits sperm mobility
† Inhibits sperm/mucus interaction
† Toxic to early (2-cell) and mature embryo (12–20 weeks)
IFN-g † Increases † Inhibits sperm mobility
† Promotes trophoblast differentiation
† Toxic to early (2-cell) and mature (12–20 weeks) embryo
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far as cytokine requirements are fulﬁlled. These
events, however, become a difﬁcult task to achieve in
endometriotic women. Depending on the stage of
endometriosis severity, the site of endometrioma
implantation and the general pathology of the
organism, the ideal approach would be to speciﬁcally
modulate the cytokine proﬁle in order to allow ovula-
tion, fertilization and implantation to occur. Although
this issue has not yet been experimentally investigated,
it is likely that following the cytokinic proﬁle during
the menstrual cycle of endometriotic women will
determine the cytokines contributing to the negative
feedback mechanisms. Such diagnosis could lead to a
speciﬁc intervention and thus treatment of the woman
by using pharmaceutically approved cytokine
inhibitors, antagonists, humanized antibodies, etc.
In particular, it seems that the initial regulation of
IFN-g and TNF-a followed by the regulation of IL-1b
and CSF-1 is the most important issue to deal with,
since as mentioned above, these two are the up-to-now
known cytokines that interfere with the ﬁrst events of
the conceptional and gestational cycle.
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